News
OSRH
0.4025
-0.12%
-0.0005
Weekly Report: what happened at OSRH last week (0601-0605)?
Weekly Report · 1d ago
OSR Holdings continues ‘to work closely’ with Nasdaq to regain compliance
TipRanks · 6d ago
OSR Holdings Secures VXM01 Rights in Asset Deal
TipRanks · 06/02 17:47
OSR Holdings agrees to buy VXM01 intellectual property assets from Vaximm for $30 million
PUBT · 06/02 17:17
Weekly Report: what happened at OSRH last week (0525-0529)?
Weekly Report · 06/01 10:18
OSR Holdings acquires full VXM01 intellectual property portfolio for $30M
TipRanks · 05/27 15:40
OSR Holdings buys VXM01 IP portfolio from Vaximm for $30 million
PUBT · 05/27 13:09
OSR Holdings Inks Deal To Acquire Full Global Intellectual Property Portfolio, Related Assets Of VAXIMM For $30M
Benzinga · 05/27 13:07
Weekly Report: what happened at OSRH last week (0518-0522)?
Weekly Report · 05/25 10:21
Weekly Report: what happened at OSRH last week (0511-0515)?
Weekly Report · 05/18 10:21
OSR Holdings Q1 EPS $(0.09) Beats $(0.29) Estimate, Sales $484.057K Miss $778.000K Estimate
Benzinga · 05/13 13:56
OSR Holdings Q1 FY26 operating loss widens 26% to $3.67 million; net sales fall 36% to $484,057
PUBT · 05/13 13:02
OSR Holdings CEO says company not pursuing reverse stock split
TipRanks · 05/12 19:35
OSR Holdings Says It Will Not Pursue Reverse Stock Split; Plans To Regain Nasdaq Compliance Through Organic Growth And Business Milestones
Benzinga · 05/12 13:17
OSR Holdings announces annual shareholder meeting notice
PUBT · 05/11 13:03
Weekly Report: what happened at OSRH last week (0504-0508)?
Weekly Report · 05/11 10:19
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 05/07 17:05
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 05/04 12:06
Weekly Report: what happened at OSRH last week (0427-0501)?
Weekly Report · 05/04 10:16
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 04/30 21:06
More
Webull provides a variety of real-time OSRH stock news. You can receive the latest news about OSR Holdings, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About OSRH
OSR Holdings, Inc. is a global healthcare holding company dedicated to advancing biomedical innovation approaches to health and wellness. Through its subsidiaries, it is engaged in immuno-oncology, regenerative biologics, and medical device technologies. Its operating businesses include developing oral immunotherapies for the treatment of cancer, developing design-augmented (DA) biologics for age-related and other degenerative diseases and neurovascular intervention medical devices and systems distribution in Korea. Its subsidiaries include VAXIMM AG (Vaximm); RMC Co., Ltd. (RMC); Darnatein Co., Ltd. (Darnatein), and Woori IO Co., Ltd. (Woori IO). Vaximm is developing oral immunotherapies for the treatment of cancer and immunological disorders. RMC is a Korea-based neurovascular intervention medical device and systems distribution company. Darnatein is developing DA biologics for age-related and other degenerative diseases. Woori IO is a South Korea-based medical device company.